X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (68720) 68720
Newspaper Article (15218) 15218
Newsletter (5763) 5763
Magazine Article (571) 571
Dissertation (329) 329
Book Chapter (229) 229
Trade Publication Article (163) 163
Web Resource (91) 91
Book Review (55) 55
Book / eBook (53) 53
Report (40) 40
Conference Proceeding (28) 28
Reference (23) 23
Transcript (22) 22
Publication (11) 11
Streaming Video (7) 7
Government Document (6) 6
Journal / eJournal (6) 6
Paper (5) 5
Video Recording (2) 2
Library Holding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (48759) 48759
hiv (33952) 33952
antiretroviral drugs (33283) 33283
human immunodeficiency virus--hiv (30627) 30627
hiv infections - drug therapy (30397) 30397
female (28344) 28344
male (28259) 28259
adult (25375) 25375
antiretroviral therapy (25361) 25361
infectious diseases (24662) 24662
highly active antiretroviral therapy (20071) 20071
aids (17454) 17454
middle aged (17042) 17042
immunology (16091) 16091
drug therapy (15936) 15936
antiviral agents (14240) 14240
acquired immune deficiency syndrome--aids (14021) 14021
hiv infection (13044) 13044
antiretroviral therapy, highly active (12835) 12835
anti-hiv agents - therapeutic use (12511) 12511
research (11045) 11045
health aspects (10487) 10487
virology (10356) 10356
viral load (9762) 9762
hiv infections - virology (9054) 9054
hiv infections - complications (9021) 9021
mortality (8997) 8997
risk factors (8912) 8912
cd4 lymphocyte count (8580) 8580
active antiretroviral therapy (8072) 8072
infection (7653) 7653
hiv patients (7609) 7609
human-immunodeficiency-virus (7499) 7499
infections (7487) 7487
care and treatment (7244) 7244
hiv infections - immunology (6820) 6820
aids/hiv (6787) 6787
adolescent (6732) 6732
hiv infections - epidemiology (6625) 6625
human immunodeficiency virus (6576) 6576
treatment outcome (6453) 6453
microbiology (6411) 6411
analysis (6312) 6312
young adult (6292) 6292
public, environmental & occupational health (6091) 6091
antiretroviral agents (6073) 6073
therapy (5590) 5590
hiv-1 (5398) 5398
prevention (5396) 5396
prevalence (5385) 5385
patients (5356) 5356
medicine (5279) 5279
pharmacology & pharmacy (5242) 5242
hiv/aids (5170) 5170
drug resistance (4952) 4952
protease inhibitors (4902) 4902
hiv-1 - drug effects (4901) 4901
research article (4872) 4872
cohort studies (4782) 4782
virus diseases (4762) 4762
viruses (4713) 4713
aged (4699) 4699
anti-retroviral agents - therapeutic use (4656) 4656
medical research (4578) 4578
adherence (4436) 4436
pregnancy (4112) 4112
public health (4100) 4100
hiv-1 - genetics (4045) 4045
retrospective studies (3980) 3980
studies (3898) 3898
anti-hiv agents - administration & dosage (3897) 3897
acquired immune deficiency syndrome (3855) 3855
medicine, general & internal (3765) 3765
risk (3757) 3757
adults (3732) 3732
multidisciplinary sciences (3679) 3679
cross-sectional studies (3647) 3647
epidemiology (3544) 3544
child (3543) 3543
prospective studies (3543) 3543
hiv infections - prevention & control (3503) 3503
cd4 antigen (3476) 3476
disease transmission (3463) 3463
usage (3411) 3411
tuberculosis (3384) 3384
disease (3370) 3370
drug therapy, combination (3348) 3348
medicine, experimental (3333) 3333
patient compliance (3242) 3242
drugs (3236) 3236
clinical trials (3231) 3231
science (3207) 3207
haart (3186) 3186
anti-hiv agents - adverse effects (3175) 3175
women (3150) 3150
antiretroviral therapy, highly active - methods (3134) 3134
antiretrovirals (3117) 3117
children (3117) 3117
hiv infections - psychology (3089) 3089
antiretroviral therapy, highly active - adverse effects (3065) 3065
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (31) 31
Gerstein Science - Stacks (22) 22
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
New College (Ivey) - Stacks (4) 4
UofT at Scarborough - Stacks (3) 3
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Missing (1) 1
Media Commons - Audio Visual (1) 1
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
UofT at Scarborough - Circulation Desk (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (89661) 89661
Spanish (673) 673
Portuguese (662) 662
French (569) 569
German (355) 355
Chinese (179) 179
Japanese (131) 131
Russian (76) 76
Italian (61) 61
Polish (38) 38
Dutch (29) 29
Norwegian (21) 21
Turkish (15) 15
Czech (13) 13
Danish (13) 13
Afrikaans (10) 10
Urdu (10) 10
Hebrew (8) 8
Korean (7) 7
Romanian (7) 7
Croatian (5) 5
Serbian (5) 5
Swedish (4) 4
Ukrainian (4) 4
Indonesian (3) 3
Persian (3) 3
Finnish (2) 2
Hungarian (2) 2
Arabic (1) 1
Breton (1) 1
Hindi (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS pathogens, ISSN 1553-7374, 2015, Volume 11, Issue 9, p. e1005142
Pharmacologically-induced activation of replication competent proviruses from latency in the presence of antiretroviral treatment (ART) has been proposed as a... 
ACTIVATION | RNA | PERSISTENCE | CD4(+) T-CELLS | MICROBIOLOGY | VIROLOGY | HISTONE DEACETYLASES | ACTIVE ANTIRETROVIRAL THERAPY | IMMUNODEFICIENCY-VIRUS TYPE-1 | STEM-CELL | INFECTION | PARASITOLOGY | VIRAL RESERVOIR | Follow-Up Studies | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | AIDS Vaccines - therapeutic use | Virus Latency - drug effects | AIDS Vaccines - adverse effects | Anti-HIV Agents - administration & dosage | HIV Infections - immunology | Drug Interactions | HIV-1 - physiology | Lymphocytes - immunology | Protein Processing, Post-Translational - drug effects | HIV-1 - isolation & purification | Adult | Anti-HIV Agents - therapeutic use | Female | Depsipeptides - therapeutic use | RNA, Viral - metabolism | Depsipeptides - adverse effects | Biomarkers - metabolism | Lymphocytes - metabolism | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | HIV Infections - virology | Biomarkers - blood | Histones - blood | Acetylation - drug effects | HIV-1 - immunology | Virus Activation - drug effects | Lymphocytes - drug effects | HIV Infections - drug therapy | Histones - metabolism | Infusions, Intravenous | Viral Load - drug effects | Cohort Studies | Depsipeptides - administration & dosage | HIV Infections - metabolism | Studies | Plasma | HIV | Acquired immune deficiency syndrome | Cytokines | Lymphocytes | Curing | AIDS | Infections | Human immunodeficiency virus | Research | Drug therapy
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 1/2011, Volume 50, Issue 1, pp. 25 - 39
.... An extensive drug-drug interaction programme in HIV-negative subjects has been carried out to assess the potential for pharmacokinetic interactions between etravirine and a variety of non-antiretroviral... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Drug-interactions | Ribavirin, drug interactions | Antiepileptic-drugs, drug interactions | Simvastatin, drug interactions | Voriconazole, drug interactions | Dexamethasone, drug interactions | Fibric-acid-derivatives, drug interactions | Rifampicin, drug interactions | Opioid-analgesics, drug interactions | Antidepressants, drug interactions | Atorvastatin, drug interactions | Antiretrovirals, drug interactions | Anti-infectives, drug interactions | Histamine-H2-receptor-antagonists, drug interactions | Diazepam, drug interactions | Ketoconazole, drug interactions | Fluconazole, drug interactions | Hypericum, drug interactions | HMG-CoA-reductase-inhibitors, drug interactions | Oral-contraceptives, drug interactions | Sildenafil, drug interactions | Omeprazole, drug interactions | Buprenorphine, drug interactions | Rosuvastatin, drug interactions | Non-nucleoside-reverse-transcriptase-inhibitors, drug interactions | Type-5-cyclic-nucleotide- phosphodiesterase-inhibitors, drug interactions | Corticosteroids, drug interactions | Paroxetine, drug interactions | Fluoxetine, drug interactions | Rifapentine, drug interactions | Ethinylestradiolnorethisterone, drug interactions | Ranitidine, drug interactions | Etravirine, drug interactions | Antifungals, drug interactions | Digoxin, drug interactions | Warfarin, drug interactions | Methadone, drug interactions | Fluvastatin, drug interactions | Rifabutin, drug interactions | Sertraline, drug interactions | Azithromycin, drug interactions | Pharmacokinetics | Calcineurin-inhibitors, drug interactions | Itraconazole, drug interactions | Proton-pump-inhibitors, drug interactions | Clarithromycin, drug interactions | METABOLISM | EFFICACY | METHADONE | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | HUMAN LIVER | PHARMACODYNAMICS | 2 DIFFERENT FORMULATIONS | CLINICAL PHARMACOKINETICS | Reverse Transcriptase Inhibitors - adverse effects | Reverse Transcriptase Inhibitors - pharmacokinetics | Drug Interactions | Drug-Related Side Effects and Adverse Reactions | Humans | Pyridazines - pharmacokinetics | Drug Therapy, Combination | Pyridazines - adverse effects | Etravirine | Drug interactions | Physiological aspects | Dosage and administration | Research | Properties | Drug therapy | HIV infection
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 07/2018, Volume 320, Issue 4, pp. 379 - 396
Journal Article
LANCET, ISSN 0140-6736, 08/2010, Volume 376, Issue 9739, pp. 475 - 485
We reviewed evidence from more than 900 studies and reports on the link between human rights abuses experienced by people who use drugs and vulnerability to HIV infection and access to services... 
MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | PUBLIC-HEALTH | LAW-ENFORCEMENT | INJECT DRUGS | SYRINGE EXCHANGE PROGRAMS | HARM REDUCTION | RISK ENVIRONMENT | ANTIRETROVIRAL TREATMENT | HEPATITIS-C | ACCESS | Human rights | Substance abuse treatment | Health services | Colleges & universities | Freedom of movement | Drug use | Public health
Journal Article
Journal Article
Current HIV research, ISSN 1570-162X, 2003
Journal
Nature (London), ISSN 1476-4687, 2016, Volume 530, Issue 7588, pp. 51 - 56
.... Although combinations of antiretroviral drugs usually suppress viral replication and reduce viral RNA to undetectable levels in blood, it is unclear whether treatment fully suppresses viral... 
EVOLUTION | SEQUENCE DATA | COMBINATION THERAPY | DNA | MULTIDISCIPLINARY SCIENCES | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4(+) T-CELLS | PERIPHERAL-BLOOD | INFECTION | Anti-HIV Agents - pharmacology | Carrier State - blood | Humans | Molecular Sequence Data | Phylogeny | Selection, Genetic - drug effects | Anti-HIV Agents - administration & dosage | HIV-1 - growth & development | Time Factors | HIV-1 - isolation & purification | Haplotypes - drug effects | Anti-HIV Agents - therapeutic use | Lymph Nodes - drug effects | Spatio-Temporal Analysis | HIV Infections - blood | Virus Replication - drug effects | HIV-1 - drug effects | HIV Infections - virology | Lymph Nodes - virology | HIV-1 - genetics | Sequence Analysis, DNA | Carrier State - virology | Models, Biological | Carrier State - drug therapy | Drug Resistance, Viral - drug effects | HIV Infections - drug therapy | Viral Load - drug effects | Infection | Highly active antiretroviral therapy | Care and treatment | Analysis | Patient outcomes | Physiological aspects | Development and progression | HIV (Viruses) | Health aspects | HIV infection | Haplotypes | Antiretroviral drugs | Tissue | Lymphatic system | Human immunodeficiency virus--HIV | Phylogenetics | Infections | Drug resistance
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9738, pp. 367 - 387
Summary HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs... 
Internal Medicine | SOFT-TISSUE INFECTIONS | MEDICINE, GENERAL & INTERNAL | OPIOID SUBSTITUTION TREATMENT | HEPATITIS-C VIRUS | SMOKING-CESSATION PHARMACOTHERAPIES | CLINICAL-TRIAL | TREATMENT OUTCOMES | METHADONE-MAINTENANCE | ADMINISTERED ANTIRETROVIRAL THERAPY | RANDOMIZED CONTROLLED-TRIAL | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV Infections - epidemiology | Humans | Drug Resistance, Bacterial | Narcotics - therapeutic use | Criminal Law | Anti-HIV Agents - administration & dosage | Hepatitis, Viral, Human - epidemiology | Drug Interactions | Antipsychotic Agents - therapeutic use | Substance-Related Disorders - epidemiology | Tuberculosis - drug therapy | Anti-HIV Agents - therapeutic use | HIV Infections - mortality | Substance-Related Disorders - mortality | Antitubercular Agents - therapeutic use | Mental Disorders - epidemiology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Comorbidity | AIDS-Related Opportunistic Infections - drug therapy | Evidence-Based Medicine | Narcotics - administration & dosage | Medication Adherence | Mental Disorders - drug therapy | AIDS-Related Opportunistic Infections - epidemiology | Bacterial Infections - epidemiology | HIV Infections - drug therapy | Substance-Related Disorders - drug therapy | Hepatitis, Viral, Human - drug therapy | Prisoners | Prevention | Complications and side effects | Drug addicts | Research | Drug therapy | Health aspects | HIV infection | Mental illness | Risk factors | Cardiovascular diseases
Journal Article